


Welcome to the May 2013 edition of i2P - Information to pharmacists.
Economic turbulence seems to now be arriving in Australia with forecasts of high inflation rates, which also means high interest rates following on.
This type of economic forecast also means that banks will be more fractious with their borrowers. They are already offside with pharmacy due to the high level of bankruptcies over the past two years.
There is a pent up demand for a general wage increase for pharmacists impacting at a point in this month where pharmacy gross profit generally, is in decline.
Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 4 Number 1
Volume 4 Number 2
Volume 4 Number 3
Volume 4 Number 4
Volume 4 Number 5
Volume 4 Number 6
Volume 4 Number 7
Volume 4 Number 8
Volume 4 Number 9
Volume 4 Number 10
Volume 4 Number 11
Volume 5 Number 1
Volume 5 Number 2
Volume 5 Number 3
Volume 5 Number 4
Professional Pharmacists Australia Spokesperson: Professional Pharmacists Hit Out at Abbott’s Penalty Rate Plans | open full screen
The precursor to I2P E-Magazine was a newsletter first published in February 2000.
From very humble beginnings, and with only one writer, it has now grown to a production covering almost every aspect of pharmacy in all its dimensions.
Writers and subscribers have increased to service the demand for current insights into the pharmacy industry of today.
i2P was the first attempt in Australian pharmacy to use the medium of the Internet for communication of pharmacy news, issues and events.
Our name and logo illustrate that we are fully integrated into the Information Technology medium.
We welcome any input from our readership, and you are welcome to try your hand at writing an article at any time (visit the "Contribute" link in the top navigation bar).
If you would like a specific topic researched, and presented in I2P, we are happy to do so on request.
At i2P we are dedicated to publishing all the information necessary to manage and understand the changes evolving around us, and to give perspective and structure to them.
Our writers hold strong personal opinions about their subjects and offer them with potential solutions. All are pharmacists, or people closely associated with pharmacy.
They are the first to realise that they will not have the complete answer for every problem, but they are prepared to speak out, and enter into a debate with any reader who wants to become part of this unique online community.
We hope you enjoy reading and keeping up to date with all the contemporary issues of pharmacy through the medium of i2P.
Potential subscribers should also note that we have a strict privacy policy guaranteeing that any information will not be re-used for any other purpose (a copy of the policy appears on the "SUBSCRIBE" page, as does the panel for "UNSUBSCRIBE" should you wish to discontinue your subscription.
Editor: Neil Johnston
Address: P.O Box 297 Alstonville. 2477
Dr Andrew Byrne & Associates: Effects of sublingually given naloxone in opioid-dependent human volunteers. Preston KL, Bigelow GE, Liebson IE. Drug Alcohol De | open full screen
Fiona Sartoretto Verna AIAPP: 400 sqm in Rome: the third Lapucci Pharmacy, a pharmacy full of services | open full screen
Mark Coleman: Bigger Dispensaries are not more efficient: So why have we still got the location rules? | open full screen
Anthony Huxley & Peter Krasenstein: Why extend the house if you don’t renovate it too? | open full screen
Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA: Pharmacists’ Support Service welcomes support from Meridian Lawyers | open full screen
Dr Andrew Byrne & Associates: Effects of sublingually given naloxone in opioid-dependent human volunteers. Preston KL, Bigelow GE, Liebson IE. Drug Alcohol De | open full screen
If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.